<DOC>
	<DOC>NCT01017458</DOC>
	<brief_summary>This study will assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of MK0773 in healthy older men.</brief_summary>
	<brief_title>Safety and Tolerability of MK0773 in Healthy Older Men (0773-004)</brief_title>
	<detailed_description />
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<criteria>Subject is in good general health Subject agrees to avoid excess alcohol and strenuous physical activity during the study Subject who is sexually active with partners of reproductive potential agrees to use two forms of appropriate contraception during the study Subject has significant drug allergies Subject has donated blood within the last 8 weeks or has taken an investigational drug in another clinical trial within the last 4 weeks Subject is a regular user or past abuser of any illicit drug (including alcohol) Subject drinks excessive amounts of caffeinated beverages Subject has a history of cancer Subject has a history of prostate or testicular surgery</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Healthy Adults</keyword>
</DOC>